QCM
UTHR icon

Quantinno Capital Management’s United Therapeutics UTHR Stock Holding History

Quantinno Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Buy
27,122
+5,987
+28% +$3.37M 0.02% 826
2026
Q1 		$12.5M Buy
21,135
+3,479
+20% +$1.73M 0.02% 787
2025
Q4 		$8.6M Buy
17,656
+7,994
+83% +$3.72M 0.02% 842
2025
Q3 		$4.05M Buy
9,662
+5,582
+137% +$1.88M 0.01% 987
2025
Q2 		$1.17M Buy
4,080
+1,035
+34% +$309K 0.01% 1264
2025
Q1 		$939K Buy
3,045
+734
+32% +$252K 0.01% 1173
2024
Q4 		$815K Buy
2,311
+1,003
+77% +$369K 0.01% 1109
2024
Q3 		$469K Buy
1,308
+322
+33% +$109K 0.01% 1145
2024
Q2 		$314K Buy
+986
New +$261K 0.01% 1143
2020
Q1 		– Sell
-4,170
Closed -$367K – 559
2019
Q4 		$367K Sell
4,170
-1,376
-25% -$121K 0.23% 196
2019
Q3 		$442K Buy
+5,546
New +$447K 0.3% 133
2019
Q2 		– Sell
-4,267
Closed -$501K – 524
2019
Q1 		$501K Buy
4,267
+1,592
+60% +$186K 0.32% 112
2018
Q4 		$291K Buy
+2,675
New +$310K 0.24% 213

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Quantinno Capital Management's UTHR Position: Q2 2026 in Review

Quantinno Capital Management increased its United Therapeutics (UTHR) stake by 28% in Q2 2026, buying an estimated $3.37M and bringing the position to 27,122 shares worth $14.7M. The position accounts for 0.02% of the portfolio, ranked #826.

Quantinno Capital Management first reported a position in UTHR in Q4 2018 and has held it in 13 quarters since. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Quantinno Capital Management held 27,122 shares of United Therapeutics worth $14.7M as of Q2 2026.
  • Quantinno Capital Management bought 5,987 United Therapeutics shares in Q2 2026, an estimated $3.37M.
  • United Therapeutics made up 0.02% of Quantinno Capital Management's portfolio in Q2 2026, its #826 holding.
  • Quantinno Capital Management first reported a position in United Therapeutics in Q4 2018 and has held it in 13 quarters since.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.